↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$1.9MSold on the market
1Companies
Aug 24, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 202617:11 | Aug 21, 2026 | STLNStarling Oncology, Inc. | Director | S · Sell10b5-1 | $6.51 | −298,853 | 411,976 | -42% | −$1.9M |